In a Phase III clinical trial, a novel drug termed GV-971 has shown promise for improving cognition in people with mild-to-moderate Alzheimer’s disease.
Browsing: Cognitive/neurodegenerative disorders
More evidence reported for causal link between herpes viruses and Alzheimer’s; reinvigorating research into the possible role of infections – and their treatment – in the disease.
Researchers from Tufts University have developed 3D human tissue culture models for the CNS. This may facilitate the discovery of new treatment methods for neurodegenerative diseases.
Digital brain simulates patterns of atrophy associated with neurodegenerative diseases through altering the initial starting zone of toxic proteins.
A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
Chinese tech firm Tencent and British healthcare technology company Medopad are joining forces to develop an artificial intelligence model with the ability to assess motor function in patients with Parkinson’s disease.
A recent study indicates that a chronic periodontal pathogen infection could result in the development of Alzheimer’s disease.
Researchers have revealed that reducing mutant huntingtin protein in the brain could restore cognitive and psychiatric impairments in mice.
Find out more about how we marked World Alzheimer’s Month this year, including our fundraising event, campaign and #TalkDementia Twitter chat.